|
2023-05-30 |
2023-05-25 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
50,000
+1.2%
1.72
USD 86,000
|
50,000
+1.2%
|
1.72
|
USD 86,000
|
|
|
2023-05-24 |
2023-05-22 |
S
Sale
|
GADICKE ANSBERT
Non-Executive Director
Large shareholder
|
70,170
-18.8%
1.88
USD 131,920
|
70,170
-18.8%
|
1.88
|
USD 131,920
|
|
|
2023-05-24 |
2023-05-22 |
S
Sale
|
MPM ASSET MANAGEMENT LLC
Large shareholder
|
70,170
-18.8%
1.88
USD 131,920
|
70,170
-18.8%
|
1.88
|
USD 131,920
|
|
|
2023-05-15 |
2023-05-12 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
6,183
+0.1%
1.95
USD 12,057
|
6,183
+0.1%
|
1.95
|
USD 12,057
|
|
|
2023-05-15 |
2023-05-11 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
38,765
+0.9%
1.95
USD 75,592
|
38,765
+0.9%
|
1.95
|
USD 75,592
|
|
|
2023-05-10 |
2023-05-10 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
6,774
+0.2%
1.95
USD 13,209
|
6,774
+0.2%
|
1.95
|
USD 13,209
|
|
|
2023-05-10 |
2023-05-09 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
20,141
+0.5%
1.95
USD 39,275
|
20,141
+0.5%
|
1.95
|
USD 39,275
|
|
|
2023-05-10 |
2023-05-08 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
57,073
+1.4%
1.95
USD 111,292
|
57,073
+1.4%
|
1.95
|
USD 111,292
|
|
|
2023-05-05 |
2023-05-05 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
71,064
+1.7%
1.94
USD 137,864
|
71,064
+1.7%
|
1.94
|
USD 137,864
|
|
|
2023-05-05 |
2023-05-05 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
95,759
+2.4%
1.90
USD 181,942
|
95,759
+2.4%
|
1.90
|
USD 181,942
|
|
|
2023-05-05 |
2023-05-04 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
104,241
+2.6%
1.86
USD 193,888
|
104,241
+2.6%
|
1.86
|
USD 193,888
|
|
|
2023-05-05 |
2023-05-03 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
18,513
+0.5%
1.85
USD 34,249
|
18,513
+0.5%
|
1.85
|
USD 34,249
|
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,659
-6.4%
1.07
USD 1,767
|
1,659
-6.4%
|
1.07
|
USD 1,767
|
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
11,000
-7.3%
1.06
USD 11,682
|
11,000
-7.3%
|
1.06
|
USD 11,682
|
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,752
-4.2%
1.06
USD 5,042
|
4,752
-4.2%
|
1.06
|
USD 5,042
|
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,610
-5.9%
1.10
USD 1,766
|
1,610
-5.9%
|
1.10
|
USD 1,766
|
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
10,613
-6.6%
1.10
USD 11,674
|
10,613
-6.6%
|
1.10
|
USD 11,674
|
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,963
-5.7%
1.06
USD 3,150
|
2,963
-5.7%
|
1.06
|
USD 3,150
|
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,865
-5.2%
1.10
USD 3,149
|
2,865
-5.2%
|
1.10
|
USD 3,149
|
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,586
-3.9%
1.10
USD 5,040
|
4,586
-3.9%
|
1.10
|
USD 5,040
|
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,561
-5.4%
1.13
USD 1,765
|
1,561
-5.4%
|
1.13
|
USD 1,765
|
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
10,325
-6.0%
1.13
USD 11,678
|
10,325
-6.0%
|
1.13
|
USD 11,678
|
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,792
-4.9%
1.13
USD 3,149
|
2,792
-4.9%
|
1.13
|
USD 3,149
|
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,461
-3.6%
1.13
USD 5,041
|
4,461
-3.6%
|
1.13
|
USD 5,041
|
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,014
-3.2%
1.26
USD 5,042
|
4,014
-3.2%
|
1.26
|
USD 5,042
|
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,511
-4.2%
1.26
USD 3,151
|
2,511
-4.2%
|
1.26
|
USD 3,151
|
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
9,314
-5.2%
1.25
USD 11,680
|
9,314
-5.2%
|
1.25
|
USD 11,680
|
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,410
-4.6%
1.25
USD 1,767
|
1,410
-4.6%
|
1.25
|
USD 1,767
|
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,928
-3.0%
1.28
USD 5,040
|
3,928
-3.0%
|
1.28
|
USD 5,040
|
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,457
-3.9%
1.28
USD 3,150
|
2,457
-3.9%
|
1.28
|
USD 3,150
|
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
9,111
-4.8%
1.28
USD 11,680
|
9,111
-4.8%
|
1.28
|
USD 11,680
|
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,378
-4.3%
1.28
USD 1,767
|
1,378
-4.3%
|
1.28
|
USD 1,767
|
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,361
-3.6%
1.33
USD 3,150
|
2,361
-3.6%
|
1.33
|
USD 3,150
|
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,327
-4.0%
1.33
USD 1,765
|
1,327
-4.0%
|
1.33
|
USD 1,765
|
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,778
-2.8%
1.33
USD 5,040
|
3,778
-2.8%
|
1.33
|
USD 5,040
|
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
14,886
-7.3%
1.35
USD 20,081
|
14,886
-7.3%
|
1.35
|
USD 20,081
|
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,302
-3.4%
1.37
USD 3,161
|
2,302
-3.4%
|
1.37
|
USD 3,161
|
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,291
-3.8%
1.37
USD 1,766
|
1,291
-3.8%
|
1.37
|
USD 1,766
|
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,686
-2.7%
1.37
USD 5,050
|
3,686
-2.7%
|
1.37
|
USD 5,050
|
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
8,530
-4.0%
1.37
USD 11,703
|
8,530
-4.0%
|
1.37
|
USD 11,703
|
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,273
-3.3%
1.39
USD 3,162
|
2,273
-3.3%
|
1.39
|
USD 3,162
|
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,273
-3.6%
1.39
USD 1,766
|
1,273
-3.6%
|
1.39
|
USD 1,766
|
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Menzel Garry E
President & CEO
Executive Director
|
8,408
-3.8%
1.39
USD 11,687
|
8,408
-3.8%
|
1.39
|
USD 11,687
|
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,636
-2.6%
1.39
USD 5,054
|
3,636
-2.6%
|
1.39
|
USD 5,054
|
|
|
2020-12-16 |
2020-12-14 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
2,000
-57.6%
35.00
USD 70,000
|
2,000
-57.6%
|
35.00
|
USD 70,000
|
|
|
2020-11-19 |
2020-11-17 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
1,666
-53.1%
30.00
USD 49,980
|
1,666
-53.1%
|
30.00
|
USD 49,980
|
|
|
2020-11-19 |
2020-11-17 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
2,000
-38.9%
30.00
USD 60,000
|
2,000
-38.9%
|
30.00
|
USD 60,000
|
|
|
2020-11-13 |
2020-11-12 |
PS
Planned sale
|
Hofmeister Robert
Chief Scientific Officer
Officer
|
10,002
-20.5%
25.10
USD 251,050
|
10,002
-20.5%
|
25.10
|
USD 251,050
|
|
|
2020-11-13 |
2020-11-12 |
PS
Planned sale
|
Hofmeister Robert
Chief Scientific Officer
Officer
|
9,998
-20.5%
25.10
USD 250,950
|
9,998
-20.5%
|
25.10
|
USD 250,950
|
|
|
2020-11-02 |
2020-10-29 |
PS
Planned sale
|
Hofmeister Robert
Chief Science Officer
Officer
|
20,000
-34.0%
19.10
USD 382,000
|
20,000
-34.0%
|
19.10
|
USD 382,000
|
|
|
2020-03-27 |
2020-03-20 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
648
-100.0%
7.94
USD 5,145
|
648
-100.0%
|
7.94
|
USD 5,145
|
|
|
2020-03-27 |
2020-03-19 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,140
-82.9%
7.41
USD 23,267
|
3,140
-82.9%
|
7.41
|
USD 23,267
|
|
|
2020-03-27 |
2020-03-18 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,120
-45.2%
6.83
USD 21,310
|
3,120
-45.2%
|
6.83
|
USD 21,310
|
|
|
2020-03-27 |
2020-03-17 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,009
-30.3%
6.49
USD 19,528
|
3,009
-30.3%
|
6.49
|
USD 19,528
|
|
|
2020-03-27 |
2020-03-16 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
17,723
-64.1%
6.60
USD 117,043
|
17,723
-64.1%
|
6.60
|
USD 117,043
|
|
|
2020-03-27 |
2020-03-13 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
52,000
-65.3%
6.52
USD 338,894
|
52,000
-65.3%
|
6.52
|
USD 338,894
|
|
|
2019-12-26 |
2019-12-23 |
PS
Planned sale
|
Baeuerle Patrick
Non-Executive Director
|
84,907
-19.5%
15.44
USD 1,310,964
|
84,907
-19.5%
|
15.44
|
USD 1,310,964
|
|
|
2019-12-26 |
2019-12-20 |
PS
Planned sale
|
Baeuerle Patrick
Non-Executive Director
|
32,022
-6.8%
15.16
USD 485,454
|
32,022
-6.8%
|
15.16
|
USD 485,454
|
|
|
2019-12-20 |
2019-12-19 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
35,323
-18.5%
16.47
USD 581,819
|
35,323
-18.5%
|
16.47
|
USD 581,819
|
|
|
2019-12-20 |
2019-12-19 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
6,642
-7.4%
16.47
USD 109,403
|
6,642
-7.4%
|
16.47
|
USD 109,403
|
|
|
2019-12-20 |
2019-12-18 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
2,433
-1.3%
17.01
USD 41,376
|
2,433
-1.3%
|
17.01
|
USD 41,376
|
|
|
2019-12-20 |
2019-12-18 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
458
-0.5%
17.01
USD 7,789
|
458
-0.5%
|
17.01
|
USD 7,789
|
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
4,153
-0.3%
17.65
USD 73,311
|
4,153
-0.3%
|
17.65
|
USD 73,311
|
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,054
-0.3%
17.65
USD 18,606
|
1,054
-0.3%
|
17.65
|
USD 18,606
|
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,381
-0.3%
17.65
USD 24,378
|
1,381
-0.3%
|
17.65
|
USD 24,378
|
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,155
-0.3%
17.65
USD 20,389
|
1,155
-0.3%
|
17.65
|
USD 20,389
|
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
30,475
-2.3%
17.62
USD 537,067
|
30,475
-2.3%
|
17.62
|
USD 537,067
|
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
7,741
-2.3%
17.62
USD 136,421
|
7,741
-2.3%
|
17.62
|
USD 136,421
|
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
10,135
-2.3%
17.62
USD 178,611
|
10,135
-2.3%
|
17.62
|
USD 178,611
|
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
8,479
-2.3%
17.62
USD 149,427
|
8,479
-2.3%
|
17.62
|
USD 149,427
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
75,067
-5.3%
17.65
USD 1,325,015
|
75,067
-5.3%
|
17.65
|
USD 1,325,015
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
19,070
-5.3%
17.65
USD 336,606
|
19,070
-5.3%
|
17.65
|
USD 336,606
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
24,966
-5.3%
17.65
USD 440,677
|
24,966
-5.3%
|
17.65
|
USD 440,677
|
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
20,886
-5.3%
17.65
USD 368,661
|
20,886
-5.3%
|
17.65
|
USD 368,661
|
|
|
2019-10-24 |
2019-10-22 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
2,085
-0.1%
15.16
USD 31,603
|
2,085
-0.1%
|
15.16
|
USD 31,603
|
|
